Posted on September 5, 2017

Featured Studies

Ulcerative Colitis

Do you experience the discomfort of ulcerative colitis? If so, you may qualify for a clinical research study at ClinSearch.

Visit our website to learn more about this enrolling study.

 

IBS-C or IBS-D

Do you suffer with the symptoms of irritable bowel syndrome? Volunteers with either IBS-C or IBS-D are needed for current studies at our site.

Visit us for more information about IBS-C and IBS-D.

 

Gastroparesis

Gastroparesis is a condition in which your stomach cannot empty itself of food in a normal fashion.

If you are interested in participating in one of our Gastroparesis studies, visit us here.

 

Other Studies

Fibromyalgia
We are studying a new treatment for Fibromyalgia. Patients must be 18-79 with a confirmed diagnosis of fibromyalgia. Other qualifications may apply.

There is no cost for this study and you may be compensated for your time and travel.

Visit our website to learn more and to see if you qualify.

 

Crohn’s Disease
There are 1.4 million Americans with Crohn’s disease. ClinSearch is conducting new research on the treatment of this disease.
Check out Dr. Krause’s recent blog post to learn more about this condition and the studies we are doing here at ClinSearch.

 

Nonalcoholic Steatohepatitis or Fatty Liver?

ClinSearch is currently enrolling for a clinical research study for the treatment of cirrhosis from NASH.

Visit our website to find out more about this study.

 

Type 2 Diabetes and High Triglycerides

If you have type 2 diabetes and high triglycerides you may qualify for a study at ClinSearch.

Find out more here.

 

Type 1 and Type 2 Diabetes

ClinSearch will be enrolling studies for individuals with either Type 1 or Type 2 diabetes. If you experience either of these conditions you may qualify for our clinical research studies.

To learn more visit our website here.

 

Sjorgren’s Syndrome

Dry mouth and eyes from Sjogren’s syndrome? If so, you may qualify for a clinical research study at ClinSearch examining an investigational medication for individuals with Sjogren’s syndrome.

Learn about the study here.

Leave a Reply

  • (will not be published)